Skip to main content
Search
Cures
Roadmap to Cures
Where We’ve Been
Roadmap 1.0
Delivery
Viral
Non-Viral
Small RNA
Cargo
Gene Therapy
Base Editing
Prime Editing
MECP2 Reactivation
RNA Editing
RNA Trans-splicing
Tracking
Rett Syndrome Global Registry
Citizen Health
Biomarkers
Biosensors
VIBRANT
Families
Was your child
recently diagnosed?
We’re here for you.
Reach Out Now
Recently Diagnosed
For All Families
About Rett Syndrome
Genetics Primer
Rett Syndrome Global Registry
Rett Clinics & Clinical Trials
Thriving with Rett Guides
Rett Fact Cards
Researchers
Fundraise
Start Your Own
Crowdfunding Page
We’ll get you set up!
Get Started
Get Started Now
Join Us
Events
RettGive Campaigns
Facebook Fundraisers
Donate
About Us
News
Get timely, factual news about Rett syndrome.
Browse News
Articles
Research
Community
Fundraising
Press Releases
Rett in the News
Donate
Join Us
Donate
Join Us
Cures
Roadmap to Cures
Where We’ve Been
Roadmap 1.0
Delivery
Viral
Non-Viral
Small RNA
Cargo
Gene Therapy
Base Editing
Prime Editing
MECP2 Reactivation
RNA Editing
RNA Trans-splicing
Tracking
Rett Syndrome Global Registry
Citizen Health
Biomarkers
Biosensors
VIBRANT
Families
Recently Diagnosed
For All Families
About Rett Syndrome
Genetics Primer
Rett Syndrome Global Registry
Rett Clinics & Clinical Trials
Thriving with Rett Guides
Rett Fact Cards
Researchers
Fundraise
Get Started Now
Join Us
Events
RettGive Campaigns
Facebook Fundraisers
Donate
About Us
News
Articles
Research
Community
Fundraising
Press Releases
Rett in the News
Rett Syndrome Global Registry
RettGive
Search
Neurogene
November 6, 2025
Neurogene Doses First Participant in Embolden™ Registrational Trial of NGN-401 for Rett Syndrome
June 30, 2025
Neurogene Announces Trial Design for Embolden™ Study of NGN-401 Gene Therapy for Rett Syndrome
April 18, 2025
How Will Cuts to FDA and NIH Impact Gene Therapy Clinical Trials and Rett Syndrome Research?
January 15, 2025
A Review of Gene Therapy Clinical Trials
November 30, 2024
Staying Resolute in Challenging Times
November 21, 2024
With Heavy Hearts
November 18, 2024
Neurogene Releases Update on NGN-401 Clinical Trial High Dose
November 11, 2024
Neurogene Announces Interim Results from Gene Therapy Clinical Trial
June 3, 2024
FDA Selects Neurogene Rett Program for START Pilot Program
March 4, 2024
Neurogene Announces Updates to Pediatric Gene Therapy Clinical Trial
January 16, 2024
A Concise Summary of Gene Therapy Clinical Trials for Rett Syndrome
November 30, 2023
Neurogene Doses First Two Patients in Pediatric US Trial
June 12, 2023
Details on Neurogene Gene Therapy Trial Now on ClinicalTrial.gov
April 18, 2023
Neurogene Shares Key Information on Gene Therapy Clinical Trial with the Rett Community
January 23, 2023
Neurogene Receives FDA Approval for Gene Replacement Clinical Trial for Rett Syndrome
December 19, 2022
What We Accomplished in 2022
November 29, 2022
Leading the Cure for Rett: In Gene Replacement, There’s No Replacement for RSRT
July 1, 2022
A Conversation with Neurogene's Leadership
1
2
$
40M
Take Action